Multiple myeloma is a clonal plasma cell proliferative disorder characterized by the abnormal increase of monoclonal paraprotein leading to evidence of specific end-organ damage. The consequences of undiagnosed disease are severe. This activity reviews the underlying cause, presentation, diagnosis, and treatment of multiple myeloma. The importance of early recognition, treatment, and an interprofessional approach is highlighted in this activity.
This activity has been designed to meet the educational needs of physicians.
Describe the pathophysiology of multiple myeloma.
Review the appropriate steps in evaluating a patient suspected of having multiple myeloma.
Summarize the first-line therapy options for multiple myeloma.
Outline the adverse effects of the disease process as well as treatment-related side effects
Tara K. Gregory, MD
Disclosure: There are no relevant financial relationships to report for those individuals in a position to control the content of this CME Activity
Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
- 1.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance
- Register for the activity and create a profile including login/password.
- Review the required accreditation information: Target audience, learning objectives, and disclosure information.
- Complete the entire activity.
- Complete the post-test assessments.
- Successfully pass the post-test with a minimum score of 70%.
- Complete the evaluation survey.
- Obtain a certificate.